Tumor infection by oncolytic reovirus primes adaptive antitumor immunity.

MLA

Prestwich, Robin J., et al. “Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 14, no. 22, Nov. 2008, pp. 7358–66. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-08-0831.

APA

Prestwich, R. J., Errington, F., Ilett, E. J., Morgan, R. S. M., Scott, K. J., Kottke, T., Thompson, J., Morrison, E. E., Harrington, K. J., Pandha, H. S., Selby, P. J., Vile, R. G., & Melcher, A. A. (2008). Tumor infection by oncolytic reovirus primes adaptive antitumor immunity. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(22), 7358–7366. https://doi.org/10.1158/1078-0432.CCR-08-0831

Chicago

Prestwich, Robin J, Fiona Errington, Elizabeth J Ilett, Ruth S M Morgan, Karen J Scott, Timothy Kottke, Jill Thompson, et al. 2008. “Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 14 (22): 7358–66. doi:10.1158/1078-0432.CCR-08-0831.